187 related articles for article (PubMed ID: 1677641)
1. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
[TBL] [Abstract][Full Text] [Related]
2. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
Horichi N; Tapiero H; Sugimoto Y; Bungo M; Nishiyama M; Fourcade A; Lampidis TJ; Kasahara K; Sasaki Y; Takahashi T
Cancer Res; 1990 Aug; 50(15):4698-701. PubMed ID: 2164445
[TBL] [Abstract][Full Text] [Related]
3. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
Nishio K; Sugimoto Y; Nakagawa K; Niimi S; Fujiwara Y; Bungo M; Kasahara K; Fujiki H; Saijo N
Br J Cancer; 1990 Sep; 62(3):415-9. PubMed ID: 2206949
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line.
Takeda Y; Nishio K; Niitani H; Saijo N
Int J Cancer; 1994 Apr; 57(2):229-39. PubMed ID: 7908894
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
7. Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18.
Sugimoto Y; Okochi E; Hamada H; Oh-hara T; Tsuruo T
Biochem Biophys Res Commun; 1990 Jun; 169(2):686-91. PubMed ID: 1972622
[TBL] [Abstract][Full Text] [Related]
8. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
[TBL] [Abstract][Full Text] [Related]
9. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
10. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation.
Asano T; Nakamura K; Fujii H; Horichi N; Ohmori T; Hasegawa K; Isoe T; Adachi M; Otake N; Fukunaga Y
Br J Cancer; 2005 Apr; 92(8):1486-92. PubMed ID: 15798770
[TBL] [Abstract][Full Text] [Related]
12. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract][Full Text] [Related]
14. SLC25A40 Facilitates Anticancer Drug Resistance in Human Leukemia K562 Cells.
Kudo N; Kouno R; Shibayama Y
Biol Pharm Bull; 2023 Sep; 46(9):1304-1309. PubMed ID: 37407483
[TBL] [Abstract][Full Text] [Related]
15. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization and cellular pharmacokinetics of MX2, a new morpholino anthracycline in glioma cells using confocal laser scanning microscopy.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Arai Y; Kitai R
Neurol Res; 1994 Aug; 16(4):257-64. PubMed ID: 7984256
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line.
Sugawara I; Mizumoto K; Ohkochi E; Hamada H; Tsuruo T; Mori S
Jpn J Cancer Res; 1989 May; 80(5):469-74. PubMed ID: 2568983
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line.
Marks DC; Davey MW; Davey RA; Kidman AD
Biochem Pharmacol; 1995 Aug; 50(4):475-80. PubMed ID: 7646552
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
[TBL] [Abstract][Full Text] [Related]
20. 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs.
Efferth T; Futscher BW; Osieka R
Blood Cells Mol Dis; 2001; 27(3):637-48. PubMed ID: 11482878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]